Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 480
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,461 Results (Page 90 of 124)
- Relevance
  Sort by

HDAC Inhibitors Market 2023-2027

 Report
January 2023
157 Pages
Global

From

€2451EUR$2,500USD£2,043GBP

Transient Ischemic Attack - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1373EUR$1,400USD£1,144GBP

€1961EUR$2,000USD£1,634GBP

Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029

 Report
February 2024
112 Pages
Global

From

€4658EUR$4,750USD£3,881GBP

Bone Cancer Treatment Market by Bone Cancer Type, Treatment Type, by Distribution Channel, and By Region

 Report
March 2024
200 Pages
Global

From

€4069EUR$4,150USD£3,391GBP

Kaposi Sarcoma Market by Type, by Treatment, by End-Users, and By Region

 Report
March 2024
200 Pages
Global

From

€4069EUR$4,150USD£3,391GBP

NEED HELP FINDING THE RIGHT PRODUCT? Eman will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Myocardial Infarction - Market Insight, Epidemiology And Market Forecast - 2032

 Report
February 2023
220 Pages
Global

From

€5148EUR$5,250USD£4,290GBP

€7354EUR$7,500USD£6,128GBP

Interleukin Inhibitors Global Market Report 2024

 Report
February 2024
250 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Biological Therapies for Cancer: Technologies and Global Markets 2021-2026

 Report
September 2021
258 Pages
Global

From

€2697EUR$2,750USD£2,247GBP

€5393EUR$5,500USD£4,494GBP

Needle-Free Devices: Technologies and Global Markets

 Report
March 2019
170 Pages
Global

From

€1348EUR$1,375USD£1,123GBP

€2697EUR$2,750USD£2,247GBP

Interferons Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Mucopolysaccharidosis Treatment Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Myositis - Pipeline Insight, 2024

 Drug Pipelines
November 2024
80 Pages
Global

From

€1961EUR$2,000USD£1,634GBP

Recombinant Proteins Market by Product, Services, End-User, Function - Global Forecast 2025-2030

 Report
October 2024
185 Pages
Global

From

€3476EUR$3,545USD£2,897GBP

€3863EUR$3,939USD£3,219GBP

Anti-Inflammatory Therapeutics Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Crohn's Disease (CD) Treatment Global Market Report 2024

 Report
January 2024
175 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

Autoimmune Treatment Global Market Report 2024

 Report
February 2024
200 Pages
Global

From

€4903EUR$5,000USD£4,085GBP

TNF Inhibitors Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
115 Pages
Global

From

€4658EUR$4,750USD£3,881GBP

Analgesics Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5883EUR$5,999USD£4,902GBP

Europe Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
120 Pages
Europe

From

€1471EUR$1,500USD£1,226GBP

North America Rare Diseases Treatment Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Specialty Pharmacy, Hospital Pharmacy, and Online Pharmacy), By Route of Administration, By Therapeutic Area, By Country and Growth Forecast, 2022 - 2028

 Report
August 2022
104 Pages
North America

From

€1471EUR$1,500USD£1,226GBP

2,461 Results (Page 90 of 124)
- 1
- 88
- 89
- 90
- 91
- 92

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.